NCT07701213

Brief Summary

Preventing iron deficiency anemia is essential for strengthening adolescent health and ensuring their full development. Strategies such as improving nutrition, expanding the availability of iron-fortified products, implementing pharmacological prevention, and raising awareness play a crucial role in addressing this issue.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
3mo left

Started Jul 2026

Shorter than P25 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress7%
Jul 2026Nov 2026

First Submitted

Initial submission to the registry

July 2, 2026

Completed
12 days until next milestone

First Posted

Study publicly available on registry

July 14, 2026

Completed
11 days until next milestone

Study Start

First participant enrolled

July 25, 2026

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 30, 2026

Expected
6 days until next milestone

Study Completion

Last participant's last visit for all outcomes

November 5, 2026

Last Updated

July 14, 2026

Status Verified

July 1, 2026

Enrollment Period

3 months

First QC Date

July 2, 2026

Last Update Submit

July 8, 2026

Conditions

Keywords

Iron Deficiency Anemiablood flow restriction

Outcome Measures

Primary Outcomes (6)

  • haemoglobin concentration

    Baseline and 12 weeks

  • Serum ferritin level

    Baseline and at 12 weeks

  • Haematocrit

    Baseline and at 12 weeks

  • Red blood cell (RBC) count

    baseline and at 12 week

  • Mean corpuscular volume (MCV)

    baseline and at 12 week

  • Mean corpuscular haemoglobin (MCH)

    baseline and at 12 week

Secondary Outcomes (3)

  • Functional capacity assessed using the Incremental Shuttle Walk Test (ISWT)

    baseline and at 12 week

  • Quality of life assessed using the SF-36 questionnaire

    baseline and at 12 week

  • Estimated maximal oxygen consumption (VO₂max) derived from the ISWT

    baseline and at 12 week

Study Arms (2)

Aerobic Exercise + Blood Flow Restriction

EXPERIMENTAL

25 female will receive blood flow restriction with low intensity aerobic exercise participated in 3 months exercise training protocol, which included three walking training sessions per week on a treadmill set at a speed 3 km/h. They experienced 3 session/week and each session include 5-10 minutes warming up and five training sets (each lasting 2 min) with a 1 min rest period between each exercise session and ended with 5-10 minutes cooling down A pressure of between 140 and 200 mmHg was applied using a sphygmomanometer cuff placed at the thigh of the BFR group.

Device: aerobic exercise + blood flow restriction

Aerobic Exercise

ACTIVE COMPARATOR

25 subject participated in 3 months exercise training protocol, which included three walking training sessions per week on a treadmill set at a speed 3 km/h. They experienced 3 session/week and each session include 5-10 minutes warming up and five training sets (each lasting 2 min) with a 1 min rest period between each exercise session and ended with 5-10 minutes cooling down.

Procedure: aerobic exercise

Interventions

Twenty five females will be subjected to supervised blood flow restriction combined with aerobic exercise program. participated in 3 months exercise training protocol, which included three walking training sessions per week on a treadmill set at a speed 3 km/h. They experienced 3 session/week and each session include 5-10 minutes .A pressure of between 140 and 200 mmHg was applied using a sphygmomanometer cuff placed at the thigh of the BFR group. The pressure of the cuff was increased until the participants adapted to the restriction stimulus during the early phase of training, and this pressure was maintained used during the training protocol. The strap pressure was increased by 10 mmHg per week, such that it reached 200 mmHg by the end of 12th week. The pressure on the thigh strap was abruptly released after five completions of the exercise set.

Aerobic Exercise + Blood Flow Restriction

participated in 3 months exercise training protocol, which included three walking training sessions per week on a treadmill set at a speed 3 km/h. They experienced 3 session/week and each session include 5-10 minutes warming up and five training sets (each lasting 2 min) with a 1 min rest period between each exercise session and ended with 5-10 minutes cooling down.

Aerobic Exercise

Eligibility Criteria

Age19 Years - 25 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Hb more than 8 and less than 12 in females.
  • Age: 19-25 year.
  • BMI ranging from 25 to 29.9 kg/m2.
  • No existing inflammatory conditions including rheumatoid arthritis disorders of the lower extremities.
  • Physical activity level less than 150 min per week

You may not qualify if:

  • unstable hypertension, venous thromboembolism, hypercoagulable states, varicose veins, pregnancy, and hemophilia.
  • inherited or acquired red cell disorders (haemoglobinopathies).
  • acute or chronic infections (malaria, tuberculosis, HIV),.
  • severe anemia (Hb \<8 g/dL).
  • History of cardiovascular diseases.
  • Nutritional anemia (B12/folate)
  • Pregnancy.
  • Peripheral arterial disease.
  • Intermittent claudication.
  • Non smokers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Anemia, Iron-Deficiency

Interventions

Exercise

Condition Hierarchy (Ancestors)

Anemia, HypochromicAnemiaHematologic DiseasesHemic and Lymphatic DiseasesIron DeficienciesIron Metabolism DisordersMetabolic DiseasesNutritional and Metabolic Diseases

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological Phenomena

Central Study Contacts

noha sameh donia, assisstant lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

July 2, 2026

First Posted

July 14, 2026

Study Start

July 25, 2026

Primary Completion (Estimated)

October 30, 2026

Study Completion (Estimated)

November 5, 2026

Last Updated

July 14, 2026

Record last verified: 2026-07